Amine-surface-modified superparamagnetic iron oxide nanoparticles interfere with differentiation of human mesenchymal stem cells

Journal of Orthopaedic Research

Volumn 30, Issue 9, 2012, Pages 1499-1506

  Chang, You Kang ^a,b,c   Liu, Yu Peng ^a,d   Ho, Jennifer H ^e,f   Hsu, Shu Ching ^g   Lee, Oscar K ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^g NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

mesenchymal stem cells; multilineage differentiation; nanoparticles; superparamagnetic iron oxide

Indexed keywords

AMINE; AMPHIREGULIN; COLLAGEN TYPE 1; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; FERRIC FERROCYANIDE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; OSTEOCALCIN; SCATTER FACTOR RECEPTOR; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TRANSCRIPTION FACTOR RUNX2; VASCULOTROPIN;

ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INTERNALIZATION; MESENCHYMAL STEM CELL; MOLECULAR MECHANICS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLAST; PRIORITY JOURNAL; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRACKING; CELLS, CULTURED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, TRANSMISSION;

EID: 84863841306     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22088     Document Type: Article

References (31)

1. Arbab AS, Yocum GT, Rad AM, et al. 2005. Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18: 553-559. (Pubitemid 43013896)
2. Heymer A, Haddad D, Weber M, et al. 2008. Iron oxide labelling of human mesenchymal stem cells in collagen hydrogels for articular cartilage repair. Biomaterials 29: 1473-1483.
3. Li Z, Suzuki Y, Huang M, et al. 2008. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26: 864-873.
4. Wang L, Deng J, Wang J, et al. 2009. Superparamagnetic iron oxide does not affect the viability and function of adipose-derived stem cells, and superparamagnetic iron oxide-enhanced magnetic resonance imaging identifies viable cells. Magn Reson Imaging 27: 108-119.
5. Yang CY, Hsiao JK, Tai MF, et al. 2011. Direct labeling of hMSC with SPIO: the long-term influence on toxicity, chondrogenic differentiation capacity, and intracellular distribution. Mol Imaging Biol 13: 443-451.
6. Crabbe A, Vandeputte C, Dresselaers T, et al. 2010. Effects of MRI contrast agents on the stem cell phenotype. Cell Transplant 19: 919-936.
7. van Buul GM, Kotek G, Wielopolski PA, et al. 2011. Clinically translatable cell tracking and quantification by MRI in cartilage repair using superparamagnetic iron oxides. PLoS ONE 6: e17001.
8. So PW, Kalber T, Hunt D, et al. 2010. Efficient and rapid labeling of transplanted cell populations with superparamagnetic iron oxide nanoparticles using cell surface chemical biotinylation for in vivo monitoring by MRI. Cell Transplant 19: 419-429.
9. Zhou B, Shan H, Li D, et al. 2010. MR tracking of magnetically labeled mesenchymal stem cells in rats with liver fibrosis. Magn Reson Imaging 28: 394-399.
10. Hirokawa Y, Isoda H, Maetani YS, et al. 2009. Hepatic lesions: improved image quality and detection with the periodically rotated overlapping parallel lines with enhanced reconstruction technique-evaluation of SPIO-enhanced T2-weighted MR images. Radiology 251: 388-397.
11. Rief M, Wagner M, Franiel T, et al. 2009. Detection of focal liver lesions in unenhanced and ferucarbotran-enhanced magnetic resonance imaging: a comparison of T2-weighted breath-hold and respiratory-triggered sequences. Magn Reson Imaging 27: 1223-1229.
12. Kostura L, Kraitchman DL, Mackay AM, et al. 2004. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17: 513-517. (Pubitemid 39549429)
13. Farrell E, Wielopolski P, Pavljasevic P, et al. 2008. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun 369: 1076-1081.
14. Mailander V, Lorenz MR, Holzapfel V, et al. 2008. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol Imaging Biol 10: 138-146.
15. Schafer R, Ayturan M, Bantleon R, et al. 2008. The use of clinically approved small particles of iron oxide (SPIO) for labeling of mesenchymal stem cells aggravates clinical symptoms in experimental autoimmune encephalomyelitis and influences their in vivo distribution. Cell Transplant 17: 923-941.
16. Huang DM, Hsiao JK, Chen YC, et al. 2009. The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles. Biomaterials 30: 3645-3651.
17. Chen YC, Hsiao JK, Liu HM, et al. 2010. The inhibitory effect of superparamagnetic iron oxide nanoparticle (Ferucarbotran) on osteogenic differentiation and its signaling mechanism in human mesenchymal stem cells. Toxicol Appl Pharmacol 245: 272-279.
18. Schafer R, Bantleon R, Kehlbach R, et al. 2010. Functional investigations on human mesenchymal stem cells exposed to magnetic fields and labeled with clinically approved iron nanoparticles. BMC Cell Biol 11: 22.
19. Mailander V, Landfester K., 2009. Interaction of nanoparticles with cells. Biomacromolecules 10: 2379-23400.
20. Shieh DB, Cheng FY, Su CH, et al. 2005. Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents. Biomaterials 26: 7183-7191.
21. Schafer R, Kehlbach R, Muller M, et al. 2009. Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy 11: 68-78.
22. Lee KD, Kuo TK, Whang-Peng J, et al. 2004. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 40: 1275-1284. (Pubitemid 39657001)
23. Lee OK, Kuo TK, Chen WM, et al. 2004. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675. (Pubitemid 38268958)
24. McCarthy JR, Weissleder R., 2009. Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60: 1241-1251.
25. Singh N, Jenkins GLS, Asadi R, et al. 2010. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev 1: 5358.
26. Chen FH, Thomas AO, Hecht JT, et al. 2005. Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins. J Biol Chem 280: 32655-32661. (Pubitemid 41368309)
27. Gagarina V, Carlberg AL, Pereira-Mouries L, et al. 2008. Cartilage oligomeric matrix protein protects cells against death by elevating members of the IAP family of survival proteins. J Biol Chem 283: 648-659.
28. McBeath R, Pirone DM, Nelson CM, et al. 2004. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell 6: 483-495. (Pubitemid 38456178)
29. Qin L, Tamasi J, Raggatt L, et al. 2005. Amphiregulin is a novel growth factor involved in normal bone development and in the cellular response to parathyroid hormone stimulation. J Biol Chem 280: 3974-3981. (Pubitemid 40223866)
30. Krampera M, Pasini A, Rigo A, et al. 2005. HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation. Blood 106: 59-66. (Pubitemid 40967175)
31. Huang Z, Ren PG, Ma T, et al. 2010. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 51: 305-310.